title: Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects.
abstract: We studied 125I-insulin binding to erythrocytes from 14 patients with diabetes secondary to chronic pancreatitis or pancreatectomy and compared the results with those found in 10 patients with type I diabetes and 25 normal controls. Patients with pancreatogenic diabetes had higher 125I-insulin binding and enhanced tissue sensitivity to exogenous insulin measured with the glucose clamp technique as compared with patients with type I diabetes. Similar binding data were obtained with monocytes from 3 patients with pancreatogenic diabetes. The increase in insulin binding seemed due mainly to an increase in receptor number. The increase in insulin binding to cells from patients with pancreatogenic diabetes in comparison with cells from normal subjects was also seen in young-erythrocyte-rich fractions and in old-erythrocyte-rich fractions obtained from the mixed population of circulating erythrocytes by centrifugation in density gradient of Percoll-Pielografin. These data, in the absence of any sign of major hematological disorders, suggest that the increase in insulin receptors seen in erythrocytes and in monocytes from patients with pancreatogenic diabetes, can mirror a general phenomenon on tissues throughout the body, including major target cells for insulin and correlate with the heightened sensitivity to insulin characteristic of these patients. In conclusion, patients with pancreatogenic diabetes have increased insulin binding as compared to controls and to patients with type I diabetes with chronic hypoinsulinemia of the same degree. Thus, in addition to insulin deficiency, other factor (s), such as glucagon deficiency, are responsible for the clinical and metabolic differences between these two conditions of insulin deficiency.
authors.forename: M
authors.initials: M
authors.lastname: Muggeo
authors.forename: P
authors.initials: P
authors.lastname: Moghetti
authors.forename: P P
authors.initials: PP
authors.lastname: Faronato
authors.forename: A
authors.initials: A
authors.lastname: Valerio
authors.forename: A
authors.initials: A
authors.lastname: Tiengo
authors.forename: S
authors.initials: S
authors.lastname: Del Prato
authors.forename: R
authors.initials: R
authors.lastname: Nosadini
mesh_terms: D001773:Blood Cells / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000209:etiology* / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism*; D004905:Erythrocyte Aging; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism; D008297:Male; D009000:Monocytes / Q000378:metabolism; D010180:Pancreatectomy / Q000009:adverse effects*; D010195:Pancreatitis / Q000150:complications*; D011972:Receptor, Insulin / Q000097:blood*; D012016:Reference Values
chemical_list: D007328:Insulin; D011972:Receptor, Insulin